Pharmacokinetic/Pharmacodynamic Considerations of Beta-Lactam Antibiotics in Adult Critically Ill Patients

被引:35
作者
Masich, Anne M. [1 ]
Heavner, Mojdeh S. [1 ]
Gonzales, Jeffrey P. [1 ]
Claeys, Kimberly C. [1 ]
机构
[1] Univ Maryland, Sch Pharm, Dept Pharm Practice & Sci, Baltimore, MD 21201 USA
关键词
Beta-lactams; Critically ill; Pharmacokinetics; Pharmacodynamics; Renal replacement therapy; Extracorporeal membrane oxygenation; EXTRACORPOREAL MEMBRANE-OXYGENATION; RENAL REPLACEMENT THERAPY; CARE-UNIT PATIENTS; CONTINUOUS-INFUSION; SEVERE SEPSIS; POPULATION PHARMACOKINETICS; PIPERACILLIN-TAZOBACTAM; ANTIMICROBIAL THERAPY; PROLONGED INFUSION; DOSING SIMULATIONS;
D O I
10.1007/s11908-018-0613-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of Review Beta-lactam antibiotics are commonly prescribed in critically ill patients for a variety of infectious conditions. Our understanding of how critical illness alters beta-lactam pharmacokinetics/pharmacodynamics (PK/PD) is rapidly evolving. Recent Findings There is a growing body of literature in adult patients demonstrating that physiological alterations occurring in critically ill patients may limit our ability to optimally dose beta-lactam antibiotics to reach these PK/PD targets. These alterations include changes in volume of distribution and renal clearance with multiple, often overlapping causative pathways, including hypoalbuminemia, renal replacement therapy, and extracorporeal membrane oxygenation. Strategies to overcome these PK alterations include extended infusions and therapeutic drug monitoring. Combined data has demonstrated a possible survival benefit associated with extending beta-lactam infusions in critically ill adult patients. Summary This review highlights research on physiological derangements affecting beta-lactam concentrations and strategies to optimize beta-lactam PK/PD in critically ill adults.
引用
收藏
页数:8
相关论文
共 50 条
[41]   Optimizing dosing of antibiotics in critically ill patients [J].
Parker, Suzanne L. ;
Sime, Fekade B. ;
Roberts, Jason A. .
CURRENT OPINION IN INFECTIOUS DISEASES, 2015, 28 (06) :497-504
[42]   Health Care Costs of Target Attainment for Beta-Lactam Antibiotics in Critically Ill Patients: A Retrospective Analysis of the EXPAT Study [J].
Ewoldt, Tim M. J. ;
Abdulla, Alan ;
Hunfeld, Nicole G. M. ;
Muller, Anouk E. ;
Gommers, Diederik ;
Polinder, Suzanne ;
Koch, Birgit C. P. ;
Endeman, Henrik .
THERAPEUTIC DRUG MONITORING, 2022, 44 (01) :224-229
[43]   Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis [J].
Mohd H. Abdul-Aziz ;
Helmi Sulaiman ;
Mohd-Basri Mat-Nor ;
Vineya Rai ;
Kang K. Wong ;
Mohd S. Hasan ;
Azrin N. Abd Rahman ;
Janattul A. Jamal ;
Steven C. Wallis ;
Jeffrey Lipman ;
Christine E. Staatz ;
Jason A. Roberts .
Intensive Care Medicine, 2016, 42 :1535-1545
[44]   Suboptimal Beta-Lactam Therapy in Critically Ill Children: Risk Factors and Outcome* [J].
Van der Heggen, Tatjana ;
Dhont, Evelyn ;
Willems, Jef ;
Herck, Ingrid ;
Delanghe, Joris R. ;
Stove, Veronique ;
Verstraete, Alain G. ;
Vanhaesebrouck, Sophie ;
De Paepe, Peter ;
De Cock, Pieter A. J. G. .
PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (07) :E309-E318
[45]   A systematic review of optimal pharmacokinetic/pharmacodynamic parameters for beta-lactam therapy in infective endocarditis [J].
Robson, Christopher ;
Tan, Bryan ;
Stuart, Rhonda ;
Nicholls, Stephen ;
Rogers, Benjamin A. ;
Sandaradura, Indy .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (03) :599-612
[46]   Pharmacodynamic Thresholds for Beta-Lactam Antibiotics: A Story of Mouse Versus Man [J].
Berry, Angela, V ;
Kuti, Joseph L. .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[47]   The higher the better? Defining the optimal beta-lactam target for critically ill patients to reach infection resolution and improve outcome [J].
Scharf, Christina ;
Liebchen, Uwe ;
Paal, Michael ;
Taubert, Max ;
Vogeser, Michael ;
Irlbeck, Michael ;
Zoller, Michael ;
Schroeder, Ines .
JOURNAL OF INTENSIVE CARE, 2020, 8 (01)
[48]   Ciprofloxacin use in critically ill patients: pharmacokinetic and pharmacodynamic approaches [J].
Conil, Jean-Marie ;
Georges, Bernard ;
de Lussy, Anne ;
Khachman, Dalia ;
Seguin, Thierry ;
Ruiz, Stephanie ;
Cougot, Pierre ;
Fourcade, Olivier ;
Houin, Georges ;
Saivin, Sylvie .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (06) :505-510
[49]   Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT) [J].
Alan Abdulla ;
Annemieke Dijkstra ;
Nicole G. M. Hunfeld ;
Henrik Endeman ;
Soma Bahmany ;
Tim M. J. Ewoldt ;
Anouk E. Muller ;
Teun van Gelder ;
Diederik Gommers ;
Birgit C. P. Koch .
Critical Care, 24
[50]   Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization [J].
Sime, Fekade Bruck ;
Udy, Andrew A. ;
Roberts, Jason A. .
CURRENT OPINION IN PHARMACOLOGY, 2015, 24 :1-6